This trial is testing whether adding a light-based therapy to surgery and chemo can improve survival in people with a certain type of lung cancer.
1 Primary · 3 Secondary · Reporting Duration: 4 years
2 Treatment Groups
patients who undergo RP alone
1 of 2
patients who undergo RP plus photofrin-based PDT
1 of 2
102 Total Participants · 2 Treatment Groups
Primary Treatment: Radical Pleurectomy · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 8 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Has the FDA officially validated Radical Pleurectomy as a treatment option?
"We appraised the safety of radical pleurectomy to be 2, owing to its Phase 2 status with limited data attesting to efficacy but some evidence of security." - Anonymous Online Contributor
How many participants is this trial limited to?
"Affirmative. Evidence on clinicaltrials.gov reveals that this investigation is actively enrolling patients, with the first posting occuring on May 1st 2014 and a recent update being made July 25th 2022. 102 participants are desired between two distinct medical centres." - Anonymous Online Contributor
Is it feasible for individuals to join this trial at present?
"Affirmative. Clinicaltrials.gov provides evidence that this medical experiment, first posted on May 1st 2014, is in need of participants to move forward with the trial. The study intends to recruit 102 individuals from 2 different locations." - Anonymous Online Contributor
What former investigations have been conducted on Radical Pleurectomy?
"Currently, the landscape of Radical Pleurectomy clinical trials are in Phase 1 and 2. There is a concentration of studies running out of Philadelphia, Pennsylvania but 6 medical sites across the United States have active investigations into this procedure." - Anonymous Online Contributor